Vertex sets higher 2020 revenue target due to ‘remarkable’ CF drug sales

While other companies are tempering or staying mum on annual sales forecasts amid the COVID-19 pandemic, booming sales of its new cystic fibrosis drug have led Vertex to increase its expectations.